Thursday 29 October 2020
Home      All news      Contact us      RSS     
healtheuropa - 20 days ago

European Commission purchases 500,000 courses of Remdesivir

The European Commission has signed a joint procurement framework contract with the pharmaceutical company Gilead for the supply of up to 500,000 treatment courses of Remdesivir. The framework also provides the opportunity to increase supply beyond the 500,000 treatment courses of Veklury, the brand name for Remdesivir. There are  36 signatories of the Joint Procurement Agreement including [ ] The post European Commission purchases 500,000 courses of Remdesivir appeared first on Health Europa.


Latest News
Hashtags:   

European

 | 

Commission

 | 

purchases

 | 

courses

 | 

Remdesivir

 | 

Sources